MEDICA 2022 to Take a Look at New Digital Reality and Revolutionary Technologies
By LabMedica International staff writers Posted on 10 Oct 2022 |

As one of the world's leading medical trade fairs, MEDICA (Düsseldorf, Germany) in Düsseldorf presents innovations every year for the entire healthcare workflow, for clinical and outpatients. Among the over 4,200 companies at MEDICA 2022 (duration: 14 – 17 November) there will again be several hundred start-ups. This event, which is one of the most international trade fairs (more than 70% of all visitors hail from abroad, and about 150 nations overall are represented), is a gateway to the world for them, through which they can make contacts across all continents.
One example is the MEDICA CONNECTED HEALTHCARE FORUM (in Hall 12), a special platform for young entrepreneurs. The most important issues of the four-day-program for the year 2022 are: Connected medical things, AI & big data, robotics, the health metaverse, the future of hospitals and care centers, health monitoring and diagnostics, mobile health, digital therapeutics, mental health, and more. About a hundred chosen start-ups and scale-ups present themselves on the forum stage during the MEDICA DISRUPT Sessions. The finale of the 11th MEDICA Start-Up COMPETITION and the "14th Healthcare Innovation World Cup" are highlights of the program.
The 11th MEDICA Start-Up COMPETITION is on the lookout for innovative healthcare industry solutions, from health apps and new tools for gathering and AI-supported analysis of health data, to robotic assistance systems and new approaches in diagnostics. Until mid-September, hundreds of innovators had already registered their participation in the finale of the competition during MEDICA 2022. The 12 best finalists, chosen by a professional jury, will now pitch on 15 November at 1 p.m. to win the grand prize. A day before, on 14 November at 1 p.m., the finale for the "14th Healthcare Innovation World Cup" will start. There, another 12 chosen finalists will pitch to win with their solutions for the "Internet of Medical Things" (IoMT). The span of developments reaches from interconnected medical technological devices, wearable technologies, digital biomarkers and intelligent plasters up to smart implants.
In addition, the metaverse is going to be one of the important topics at the MEDICA CONNECTED HEALTHCARE FORUM. The new buzzword hints at a novel digital reality that focuses on technologies like virtual reality (VR) and augmented reality (AR), the possibilities of processing big data in real time by artificial intelligence, and digital twins. This could lead to revolutionary changes in health care, both for monitoring health and treatments. This trend provides the focus for the content of a symposium, starting on Wednesday, 16 November, at 12 p.m. There, Eva Garcia Ramos, CEO and co-founder of WIVI Vision, will speak. The start-up concentrates mostly on children and adolescents. The products (for example with the capacity for 3D visualization) aim to improve health care with a view to evaluating and treating problems with visual function.
Khora, a Danish start-up, will also be present on stage at the MEDICA CONNECTED HEALTHCARE FORUM. The start-up has worked with the Rigshospitalet to create, for example, an AR universe aimed at children and adolescents from ages ten to fourteen, who have to spend considerable time in hospital with cancer or leukemia. It is supposed to make daily life easier for them. Khora created "Snail Battle", which allows persons affected to use plants to fight against evil monster snails. During the MEDICA CONNECTED HEALTHCARE FORUM, CEO Simon Lajboschitz will also explain, how VR can help patients with schizophrenia affected by auditory hallucinations. The metaverse can offer opportunities in many other areas, ranging from applications for attention deficit disorder over the development and testing of medical devices on virtual patients to simulation scenarios. These will be the focus of talks on Wednesday, 16 November.
Thericon and KuartisMED are among the companies participating in the MEDICA START-UP PARK. The shared booth (also located in Hall 12) has established itself over the years as a central meeting point for business and networking with the young founders' scene, and this year counts around 40 participants. German start-up Thericon see themselves as the first company to bring imaging compiled from several different sources into the operating theatre as a visual aid. Visual representations of hitherto invisible tissue properties are presented together with standard colored images on a single monitor. This diagnostic information and their intuitive display aims to make faster and more precise surgical results possible. The company’s MEDICA START-UP PARK presentation explains how it works in detail. Meanwhile, Turkish company KuartisMED concentrates on innovative solutions for the well-being of newborns. As children born before the 34th week of gestation lack sufficient coordination of the sucking and swallowing reflexes, they depend on feeding tubes for nutrition. The non-invasive medical device by KuartisMED aims to help with evaluating the maturity of these reflexes in the future. These aforementioned examples show that for those interested in innovations in the health sector, a visit to MEDICA 2022, and especially the novelties presented by the various start-ups, is a must.
Related Links:
MEDICA
Latest Industry News
- Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
- Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
- New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
- Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
- Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration
- Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
- Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
- Research Collaboration to Advance AI-Enhanced, Real-Time Optical Imaging in Lung Cancer Biopsy
- CACLP 2025 Unites Global Innovators in IVD Industry
- Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
- ABL Signs Know-How License and Transfer Agreement for Siemens’ Fast Track Diagnostics PCR Portfolio
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- New Partnership Revolutionizes Analyses of Biological Samples
- Medlab Middle East Looks to The Future of Laboratories
- Medix Biochemica Acquires German Immunoassay Solutions Developer Candor Bioscience
- bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more